Erbin interacts with c-Cbl and promotes tumourigenesis and tumour growth in colorectal cancer by preventing c-Cbl-mediated ubiquitination and down-regulation of EGFR

Su Yao, Ping Zheng, Hua Wu, Li Ming Song, Xiao Fang Ying, Cheng Xing, Ying Li, Zheng Quan Xiao, Xing Ni Zhou, Tong Shen, Lin Chen, Yu Hong Liu, Mao De Lai, Lin Mei, Tian Ming Gao, Jian Ming Li

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The epidermal growth factor receptor (EGFR) is implicated in many types of cancer, including colorectal cancer (CRC), and has become one of the most common candidates for targeted therapy. Here, we found that Erbin, a member of the leucine-rich repeat and PDZ domain (LAP) family, plays a key role in EGFR signalling. Erbin inhibited EGFR ubiquitination and stabilized the EGFR protein by interacting with c-Cbl. Moreover, the PDZ domain of Erbin was critical for the interaction between Erbin and c-Cbl and EGFR ubiquitination. Interestingly, Erbin expression was elevated in tumour samples from CRC patients, increased in advanced clinical stage disease and correlated with EGFR expression. In vivo studies using mouse xenograft models of CRC showed that Erbin promotes tumour growth, and that the effects of Erbin on tumour growth are mainly related to the regulatory effects of Erbin on EGFR. The azoxymethane (AOM)-induced colon carcinogenesis model in ErbinΔC/ΔC mice, with the PDZ domain of Erbin deleted, demonstrated that the PDZ domain of Erbin and its regulation of EGFR signalling are necessary for the tumourigenesis and tumour growth of CRC. We found that Erbin promotes tumourigenesis and tumour growth in CRC by stabilizing EGFR. Our study sheds light on developing Erbin, especially its PDZ domain, as a potential target for CRC treatment.

Original languageEnglish (US)
Pages (from-to)65-77
Number of pages13
JournalJournal of Pathology
Volume236
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Ubiquitination
Epidermal Growth Factor Receptor
Colorectal Neoplasms
Down-Regulation
PDZ Domains
Growth
Neoplasms
Azoxymethane
Heterografts
Leucine
Colon
Carcinogenesis
Therapeutics

Keywords

  • EGFR
  • Erbin
  • colorectal cancer
  • tumour growth
  • tumourigenesis
  • ubiquitination

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Erbin interacts with c-Cbl and promotes tumourigenesis and tumour growth in colorectal cancer by preventing c-Cbl-mediated ubiquitination and down-regulation of EGFR. / Yao, Su; Zheng, Ping; Wu, Hua; Song, Li Ming; Ying, Xiao Fang; Xing, Cheng; Li, Ying; Xiao, Zheng Quan; Zhou, Xing Ni; Shen, Tong; Chen, Lin; Liu, Yu Hong; Lai, Mao De; Mei, Lin; Gao, Tian Ming; Li, Jian Ming.

In: Journal of Pathology, Vol. 236, No. 1, 01.01.2015, p. 65-77.

Research output: Contribution to journalArticle

Yao, S, Zheng, P, Wu, H, Song, LM, Ying, XF, Xing, C, Li, Y, Xiao, ZQ, Zhou, XN, Shen, T, Chen, L, Liu, YH, Lai, MD, Mei, L, Gao, TM & Li, JM 2015, 'Erbin interacts with c-Cbl and promotes tumourigenesis and tumour growth in colorectal cancer by preventing c-Cbl-mediated ubiquitination and down-regulation of EGFR', Journal of Pathology, vol. 236, no. 1, pp. 65-77. https://doi.org/10.1002/path.4502
Yao, Su ; Zheng, Ping ; Wu, Hua ; Song, Li Ming ; Ying, Xiao Fang ; Xing, Cheng ; Li, Ying ; Xiao, Zheng Quan ; Zhou, Xing Ni ; Shen, Tong ; Chen, Lin ; Liu, Yu Hong ; Lai, Mao De ; Mei, Lin ; Gao, Tian Ming ; Li, Jian Ming. / Erbin interacts with c-Cbl and promotes tumourigenesis and tumour growth in colorectal cancer by preventing c-Cbl-mediated ubiquitination and down-regulation of EGFR. In: Journal of Pathology. 2015 ; Vol. 236, No. 1. pp. 65-77.
@article{d4387d9e07c24912ad85f0e20d15352a,
title = "Erbin interacts with c-Cbl and promotes tumourigenesis and tumour growth in colorectal cancer by preventing c-Cbl-mediated ubiquitination and down-regulation of EGFR",
abstract = "The epidermal growth factor receptor (EGFR) is implicated in many types of cancer, including colorectal cancer (CRC), and has become one of the most common candidates for targeted therapy. Here, we found that Erbin, a member of the leucine-rich repeat and PDZ domain (LAP) family, plays a key role in EGFR signalling. Erbin inhibited EGFR ubiquitination and stabilized the EGFR protein by interacting with c-Cbl. Moreover, the PDZ domain of Erbin was critical for the interaction between Erbin and c-Cbl and EGFR ubiquitination. Interestingly, Erbin expression was elevated in tumour samples from CRC patients, increased in advanced clinical stage disease and correlated with EGFR expression. In vivo studies using mouse xenograft models of CRC showed that Erbin promotes tumour growth, and that the effects of Erbin on tumour growth are mainly related to the regulatory effects of Erbin on EGFR. The azoxymethane (AOM)-induced colon carcinogenesis model in ErbinΔC/ΔC mice, with the PDZ domain of Erbin deleted, demonstrated that the PDZ domain of Erbin and its regulation of EGFR signalling are necessary for the tumourigenesis and tumour growth of CRC. We found that Erbin promotes tumourigenesis and tumour growth in CRC by stabilizing EGFR. Our study sheds light on developing Erbin, especially its PDZ domain, as a potential target for CRC treatment.",
keywords = "EGFR, Erbin, colorectal cancer, tumour growth, tumourigenesis, ubiquitination",
author = "Su Yao and Ping Zheng and Hua Wu and Song, {Li Ming} and Ying, {Xiao Fang} and Cheng Xing and Ying Li and Xiao, {Zheng Quan} and Zhou, {Xing Ni} and Tong Shen and Lin Chen and Liu, {Yu Hong} and Lai, {Mao De} and Lin Mei and Gao, {Tian Ming} and Li, {Jian Ming}",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/path.4502",
language = "English (US)",
volume = "236",
pages = "65--77",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Erbin interacts with c-Cbl and promotes tumourigenesis and tumour growth in colorectal cancer by preventing c-Cbl-mediated ubiquitination and down-regulation of EGFR

AU - Yao, Su

AU - Zheng, Ping

AU - Wu, Hua

AU - Song, Li Ming

AU - Ying, Xiao Fang

AU - Xing, Cheng

AU - Li, Ying

AU - Xiao, Zheng Quan

AU - Zhou, Xing Ni

AU - Shen, Tong

AU - Chen, Lin

AU - Liu, Yu Hong

AU - Lai, Mao De

AU - Mei, Lin

AU - Gao, Tian Ming

AU - Li, Jian Ming

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The epidermal growth factor receptor (EGFR) is implicated in many types of cancer, including colorectal cancer (CRC), and has become one of the most common candidates for targeted therapy. Here, we found that Erbin, a member of the leucine-rich repeat and PDZ domain (LAP) family, plays a key role in EGFR signalling. Erbin inhibited EGFR ubiquitination and stabilized the EGFR protein by interacting with c-Cbl. Moreover, the PDZ domain of Erbin was critical for the interaction between Erbin and c-Cbl and EGFR ubiquitination. Interestingly, Erbin expression was elevated in tumour samples from CRC patients, increased in advanced clinical stage disease and correlated with EGFR expression. In vivo studies using mouse xenograft models of CRC showed that Erbin promotes tumour growth, and that the effects of Erbin on tumour growth are mainly related to the regulatory effects of Erbin on EGFR. The azoxymethane (AOM)-induced colon carcinogenesis model in ErbinΔC/ΔC mice, with the PDZ domain of Erbin deleted, demonstrated that the PDZ domain of Erbin and its regulation of EGFR signalling are necessary for the tumourigenesis and tumour growth of CRC. We found that Erbin promotes tumourigenesis and tumour growth in CRC by stabilizing EGFR. Our study sheds light on developing Erbin, especially its PDZ domain, as a potential target for CRC treatment.

AB - The epidermal growth factor receptor (EGFR) is implicated in many types of cancer, including colorectal cancer (CRC), and has become one of the most common candidates for targeted therapy. Here, we found that Erbin, a member of the leucine-rich repeat and PDZ domain (LAP) family, plays a key role in EGFR signalling. Erbin inhibited EGFR ubiquitination and stabilized the EGFR protein by interacting with c-Cbl. Moreover, the PDZ domain of Erbin was critical for the interaction between Erbin and c-Cbl and EGFR ubiquitination. Interestingly, Erbin expression was elevated in tumour samples from CRC patients, increased in advanced clinical stage disease and correlated with EGFR expression. In vivo studies using mouse xenograft models of CRC showed that Erbin promotes tumour growth, and that the effects of Erbin on tumour growth are mainly related to the regulatory effects of Erbin on EGFR. The azoxymethane (AOM)-induced colon carcinogenesis model in ErbinΔC/ΔC mice, with the PDZ domain of Erbin deleted, demonstrated that the PDZ domain of Erbin and its regulation of EGFR signalling are necessary for the tumourigenesis and tumour growth of CRC. We found that Erbin promotes tumourigenesis and tumour growth in CRC by stabilizing EGFR. Our study sheds light on developing Erbin, especially its PDZ domain, as a potential target for CRC treatment.

KW - EGFR

KW - Erbin

KW - colorectal cancer

KW - tumour growth

KW - tumourigenesis

KW - ubiquitination

UR - http://www.scopus.com/inward/record.url?scp=84927692363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927692363&partnerID=8YFLogxK

U2 - 10.1002/path.4502

DO - 10.1002/path.4502

M3 - Article

C2 - 25521828

AN - SCOPUS:84927692363

VL - 236

SP - 65

EP - 77

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 1

ER -